eCite Digital Repository

Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure


Sharman, JE and O'Brien, E and Alpert, B and Schutte, AE and Delles, C and Olsen, MH and Asmar, R and Atkins, N and Barbosa, E and Calhoun, D and Campbell, NRC and Chalmers, J and Benjamin, I and Jennings, G and Laurent, S and Boutouyrie, P and Lopez-Jaramillo, P and McManus, RJ and Mihailidou, AS and Ordunez, P and Padwal, R and Palatini, P and Parati, G and Poulter, N and Rakotz, MK and Rosendorff, C and Saladini, F and Scuteri, A and Barroso, WS and Cho, M-C and Sung, K-C and Townsend, RR and Wang, J-G and Hansen, TW and Wozniak, G and Stergiou, G, on behalf of the Lancet Commission on Hypertension Group, Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure, Journal of Hypertension, 38, (1) pp. 21-29. ISSN 0263-6352 (2020) [Refereed Article]


Copyright Statement

Copyright 2019 The Authors. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)

DOI: doi:10.1097/HJH.0000000000002246


The Lancet Commission on Hypertension identified that a key action to address the worldwide burden of high blood pressure (BP) was to improve the quality of BP measurements by using BP devices that have been validated for accuracy. Currently, there are over 3000 commercially available BP devices, but many do not have published data on accuracy testing according to established scientific standards. This problem is enabled through weak or absent regulations that allow clearance of devices for commercial use without formal validation. In addition, new BP technologies have emerged (e.g. cuffless sensors) for which there is no scientific consensus regarding BP measurement accuracy standards. Altogether, these issues contribute to the widespread availability of clinic and home BP devices with limited or uncertain accuracy, leading to inappropriate hypertension diagnosis, management and drug treatment on a global scale. The most significant problems relating to the accuracy of BP devices can be resolved by the regulatory requirement for mandatory independent validation of BP devices according to the universally-accepted International Organisation for Standardization Standard. This is a primary recommendation for which there is an urgent international need. Other key recommendations are development of validation standards specifically for new BP technologies and online lists of accurate devices that are accessible to consumers and health professionals. Recommendations are aligned with WHO policies on medical devices and universal healthcare. Adherence to recommendations would increase the global availability of accurate BP devices and result in better diagnosis and treatment of hypertension, thus decreasing the worldwide burden from high BP.

Item Details

Item Type:Refereed Article
Keywords:biomedical technology, diagnostic equipment, international health, reference standard
Research Division:Biomedical and Clinical Sciences
Research Group:Cardiovascular medicine and haematology
Research Field:Cardiology (incl. cardiovascular diseases)
Objective Division:Health
Objective Group:Clinical health
Objective Field:Clinical health not elsewhere classified
UTAS Author:Sharman, JE (Professor James Sharman)
ID Code:139335
Year Published:2020
Web of Science® Times Cited:26
Deposited By:Menzies Institute for Medical Research
Deposited On:2020-06-10
Last Modified:2021-03-25
Downloads:2 View Download Statistics

Repository Staff Only: item control page